The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

Overview of attention for article published in Frontiers in Pharmacology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,166 followers.

RT @FrontPharmacol: New Research: The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic…

25 May 2023

Reply Repost Favourite

New Research: The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials #pharmacology https://t.co/TQ8fLhGVZY

25 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.